Safety and Efficacy Study of Nimotuzumab Plus Neoadjuvant and Concurrent Chemoradiotherapy to Treat Oropharynx and Hypopharynx Cancer
Clinical trial NCT01516996 · UNKNOWN
Trial details
- NCT number
- NCT01516996
- Sponsor
- The Second People's Hospital of Sichuan
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-01
- Primary completion
- 2013-09-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.